331 related articles for article (PubMed ID: 29112174)
1. miRNAs, Melanoma and Microenvironment: An Intricate Network.
Romano G; Kwong LN
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29112174
[TBL] [Abstract][Full Text] [Related]
2. Melanoma cell-derived exosomes promote epithelial-mesenchymal transition in primary melanocytes through paracrine/autocrine signaling in the tumor microenvironment.
Xiao D; Barry S; Kmetz D; Egger M; Pan J; Rai SN; Qu J; McMasters KM; Hao H
Cancer Lett; 2016 Jul; 376(2):318-27. PubMed ID: 27063098
[TBL] [Abstract][Full Text] [Related]
3. The role of CAF derived exosomal microRNAs in the tumour microenvironment of melanoma.
Shelton M; Anene CA; Nsengimana J; Roberts W; Newton-Bishop J; Boyne JR
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188456. PubMed ID: 33153973
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs as critical regulators involved in regulating epithelial- mesenchymal transition.
Zhao X; Lu Y; Nie Y; Fan D
Curr Cancer Drug Targets; 2013 Nov; 13(9):935-44. PubMed ID: 24168189
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-Mediated Post-Transcriptional Regulation of Epithelial to Mesenchymal Transition in Cancer.
Behbahani GD; Ghahhari NM; Javidi MA; Molan AF; Feizi N; Babashah S
Pathol Oncol Res; 2017 Jan; 23(1):1-12. PubMed ID: 27590333
[TBL] [Abstract][Full Text] [Related]
6. Essential role of miRNAs in orchestrating the biology of the tumor microenvironment.
Frediani JN; Fabbri M
Mol Cancer; 2016 May; 15(1):42. PubMed ID: 27231010
[TBL] [Abstract][Full Text] [Related]
7. miRNA Deregulation in Cancer Cells and the Tumor Microenvironment.
Rupaimoole R; Calin GA; Lopez-Berestein G; Sood AK
Cancer Discov; 2016 Mar; 6(3):235-46. PubMed ID: 26865249
[TBL] [Abstract][Full Text] [Related]
8. Secreted molecules inducing epithelial-to-mesenchymal transition in cancer development.
Dalla Pozza E; Forciniti S; Palmieri M; Dando I
Semin Cell Dev Biol; 2018 Jun; 78():62-72. PubMed ID: 28673679
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs and epithelial-mesenchymal transition in prostate cancer.
Sekhon K; Bucay N; Majid S; Dahiya R; Saini S
Oncotarget; 2016 Oct; 7(41):67597-67611. PubMed ID: 27588490
[TBL] [Abstract][Full Text] [Related]
10. High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells.
Shukla P; Vogl C; Wallner B; Rigler D; Müller M; Macho-Maschler S
BMC Genomics; 2015 Nov; 16():944. PubMed ID: 26572553
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: prognostic value and prospective role in ovarian cancer therapeutics.
Koutsaki M; Spandidos DA; Zaravinos A
Cancer Lett; 2014 Sep; 351(2):173-81. PubMed ID: 24952258
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs are involved in the development and progression of gastric cancer.
Liu X; Ma R; Yi B; Riker AI; Xi Y
Acta Pharmacol Sin; 2021 Jul; 42(7):1018-1026. PubMed ID: 33037405
[TBL] [Abstract][Full Text] [Related]
13. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.
Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G
Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs-mediated epithelial-mesenchymal transition in fibrotic diseases.
Zou XZ; Liu T; Gong ZC; Hu CP; Zhang Z
Eur J Pharmacol; 2017 Feb; 796():190-206. PubMed ID: 27916556
[TBL] [Abstract][Full Text] [Related]
15. [Molecular networks and mechanisms of epithelial-mesenchymal transition regulated by miRNAs in the malignant melanoma cell line].
Wang D; Li YJ; Ding N; Wang JY; Yang Q; Yang YR; Li YM; Fang XD; Zhao H
Yi Chuan; 2015 Jul; 37(7):673-82. PubMed ID: 26351167
[TBL] [Abstract][Full Text] [Related]
16. miR-1236 regulates hypoxia-induced epithelial-mesenchymal transition and cell migration/invasion through repressing SENP1 and HDAC3.
Chen SY; Teng SC; Cheng TH; Wu KJ
Cancer Lett; 2016 Aug; 378(1):59-67. PubMed ID: 27177472
[TBL] [Abstract][Full Text] [Related]
17. Cancer stem cells, epigenetics, tumor microenvironment and future therapeutics in cutaneous malignant melanoma: a review.
Kyriakou G; Melachrinou M
Future Oncol; 2020 Jul; 16(21):1549-1567. PubMed ID: 32484008
[TBL] [Abstract][Full Text] [Related]
18. [Research Progress of Regulation of Hypoxia-mediated Signaling Pathways on Epithelial-Mesenchymal Transition of Tumor Cells].
Chen C; Zhang X; Yang L; Lu Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2016 Jun; 33(3):575-82. PubMed ID: 29709162
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients.
De Mattos-Arruda L; Bottai G; Nuciforo PG; Di Tommaso L; Giovannetti E; Peg V; Losurdo A; Pérez-Garcia J; Masci G; Corsi F; Cortés J; Seoane J; Calin GA; Santarpia L
Oncotarget; 2015 Nov; 6(35):37269-80. PubMed ID: 26452030
[TBL] [Abstract][Full Text] [Related]
20. Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer.
Garg M
Expert Opin Ther Targets; 2015 Feb; 19(2):285-97. PubMed ID: 25563894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
